Interventions developed to reduce secondary care utilisation in patients with type 2 diabetes mellitus: a narrative review
Interventions developed to reduce secondary care utilisation in patients with type 2 diabetes mellitus: a narrative review is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Interventions developed to reduce secondary care utilisation in patients with type 2 diabetes mellitus: a narrative review have?
Interventions developed to reduce secondary care utilisation in patients with type 2 diabetes mellitus: a narrative review has 4 citations in the OpenAlex counts ScholarIQ stores.
When was Interventions developed to reduce secondary care utilisation in patients with type 2 diabetes mellitus: a narrative review published?
Interventions developed to reduce secondary care utilisation in patients with type 2 diabetes mellitus: a narrative review has 2022 year in the ScholarIQ index.
What is the open-access status of Interventions developed to reduce secondary care utilisation in patients with type 2 diabetes mellitus: a narrative review?
Interventions developed to reduce secondary care utilisation in patients with type 2 diabetes mellitus: a narrative review has green oa status in the ScholarIQ index.
What is the DOI of Interventions developed to reduce secondary care utilisation in patients with type 2 diabetes mellitus: a narrative review?
The DOI for Interventions developed to reduce secondary care utilisation in patients with type 2 diabetes mellitus: a narrative review is on the source record.
What is the PMID of Interventions developed to reduce secondary care utilisation in patients with type 2 diabetes mellitus: a narrative review?
The PMID for Interventions developed to reduce secondary care utilisation in patients with type 2 diabetes mellitus: a narrative review is on the source record.
What is the OpenAlex record for Interventions developed to reduce secondary care utilisation in patients with type 2 diabetes mellitus: a narrative review?
The OpenAlex for Interventions developed to reduce secondary care utilisation in patients with type 2 diabetes mellitus: a narrative review is on the source record.